Market News AIOpen the app

EBS stock news · Emergent BioSolutions Inc.

Stories about Emergent BioSolutions Inc. (EBS) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for EBS

Follow Emergent BioSolutions Inc. (EBS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for EBS
Free on the App Store and Google Play, or on the web.
  1. Oct 16, 2026, 7:53 AM ET · Market

    Emergent BioSolutions Inc. says some directors and officers are leaving, while new ones are being chosen.

    Neutral

    Emergent BioSolutions named Treasurer Frank Vargo interim CFO as Richard Lindahl prepares to retire. The planned handoff includes transition help, but reports no change to the company's business outlook.

  2. Oct 5, 2026, 4:41 PM ET · Market

    People betting against Novavax are worried as fears of a plague in Russia grow.

    Neutral

    Emergent BioSolutions shares rose as traders reacted to fears of an outbreak. Plague is unconfirmed, and the story reports no new company contract or sales, so its business outlook is unchanged.

  3. Sep 14, 2026, 4:06 PM ET · New boss

    Emergent BioSolutions Inc. says CEO Joseph C. Papa will speak at an investment conference on September 14, 2026.

    Neutral

    Emergent filed a Regulation FD investor presentation for a Sept 14 conference; the disclosure supplies slides but no new financial data, so I read it as neutral for EBS.